QGEN
Qiagen NVNYSEHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$7.01B
P/E Ratio
16.68
EPS
$2.04
Beta
0.79
52W High
$57.82
52W Low
$33.78
50-Day MA
$42.52
200-Day MA
$46.44
Dividend Yield
0.69%
Profit Margin
20.30%
Forward P/E
11.98
PEG Ratio
0.96
About Qiagen NV
QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.
Fundamentals
| Revenue (TTM) | $2.09B |
| Gross Profit (TTM) | $1.39B |
| EBITDA | $728.29M |
| Operating Margin | 27.40% |
| Return on Equity | 11.60% |
| Return on Assets | 5.77% |
| Revenue/Share (TTM) | $10.13 |
| Book Value | $18.33 |
| Price-to-Book | 2.08 |
| Price-to-Sales (TTM) | 3.35 |
| EV/Revenue | 4.097 |
| EV/EBITDA | 11.94 |
| Quarterly Earnings Growth (YoY) | 21.90% |
| Quarterly Revenue Growth (YoY) | 3.70% |
| Shares Outstanding | $206.07M |
| Float | $204.13M |
| % Insiders | 0.46% |
| % Institutions | 75.53% |
Historical Volatility
HV 10-Day
58.09%
HV 20-Day
47.75%
HV 30-Day
41.75%
HV 60-Day
34.27%
HV Rank
85.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($53.96 target)
4
Strong Buy4
Buy8
HoldData last updated: 4/29/2026